SCHEMBL6154319

SCHEMBL6154319

O=C(O)COC(c1cccc(-c2nnc(Nc3ccc(Cl)c(Cl)c3)s2)c1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 4/20 0.45
ROCK2 O75116 3/20 0.45
GUSB P08236 2/20 0.43
S1PR1 P21453 1/20 0.42
BLM P54132 4/20 0.39
DHODH Q02127 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 2/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
DNMT1 P26358 1/20 0.38
HTT P42858 1/20 0.38
DUSP3 P51452 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
MCL1 Q07820 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154890 0.90 DHODH (0.44) ROCK1ROCK2GUSBS1PR1BLM
SCHEMBL6153621 0.88 GUSB (0.48) ROCK1ROCK2GUSBS1PR1BLM
SCHEMBL6153833 0.84 GUSB (0.48) GUSBBLMMEN1KMT2AMAPT
SCHEMBL6154382 0.83 GUSB (0.40) ROCK1ROCK2GUSBS1PR1BLM
SCHEMBL6153748 0.77 GUSB (0.54) ROCK1ROCK2GUSBBLMMEN1
SCHEMBL6684701 0.75 ROCK2 (0.42) ROCK1ROCK2GUSBS1PR1BLM
SCHEMBL6155247 0.73 CFTR (0.47) ROCK1ROCK2GUSBBLMMEN1
SCHEMBL6157213 0.73 DHODH (0.44) ROCK1ROCK2GUSBDHODHMEN1
SCHEMBL9293034 0.73 IDO1 (0.58) MEN1KMT2AALDH1A1POLBGAA
Ammonia Solution, Strong SCHEMBL10334616 0.72 IDO1 (0.57) MEN1KMT2AALDH1A1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US claimed
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP ROCK1 3290/4885ROCK2 3224/4885GUSB 2466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.